Clinical Interpretability of Deep Learning Segmentation Through Shapley-Derived Agreement and Uncertainty Metrics

Summary

This paper addresses the critical need for explainability in deep learning medical image segmentation by proposing novel Shapley-derived agreement and uncertainty metrics. By analyzing contrast-level Shapley values across different MRI sequences and model architectures, the study demonstrates that higher model performance correlates with greater agreement with clinical imaging priorities and lower uncertainty, thus offering interpretable proxies for model reliability.

Medical Relevance

This research is paramount for bridging the gap between advanced AI capabilities and clinical utility by offering transparent, interpretable metrics for deep learning segmentation models. It empowers clinicians to better understand and trust AI outputs, which is vital for informed decision-making, improving patient care, and facilitating the safe integration of AI in computer-aided diagnosis.

AI Health Application

The AI application is the development of interpretable deep learning models for medical image segmentation (e.g., identifying organs, tissues, lesions in MRI scans). These models aim to assist clinicians in computer-aided diagnosis by providing reliable and understandable insights, thereby improving the integration and trust of AI in clinical practice.

Key Points

• **Problem Addressed:** The lack of explainability in deep learning models, despite their high performance in medical image segmentation, hinders their acceptance and integration into clinical practice.
• **Novel Approach:** Utilizes contrast-level Shapley values, derived from systematic perturbation of model inputs, to quantify the importance of different MRI contrasts in model performance attribution, providing a clinically aligned explanation.
• **Methodology:** Applied Shapley value analysis to four MRI contrasts and four deep learning architectures on the BraTS 2024 dataset to generate contrast importance rankings.
• **Proposed Metrics:** Introduced two new metrics based on Shapley rankings: 'agreement' (between the model's contrast ranking and a predefined 'clinician' imaging ranking) and 'uncertainty' (quantified by the variance of Shapley rankings across cross-validation folds).
• **Finding 1 - Agreement:** Higher-performing segmentation cases (Dice > 0.6) showed significantly greater agreement with the clinical imaging contrast rankings.
• **Finding 2 - Uncertainty:** Increased Shapley ranking variance, indicating higher uncertainty in feature importance, strongly correlated with decreased model performance (e.g., U-Net: r = -0.581).
• **Clinical Implication:** These Shapley-derived metrics provide clinicians with interpretable indicators of model reliability and understanding, fostering trust and aiding in the evaluation of state-of-the-art segmentation model outputs.

Clinical Impact

The proposed Shapley-derived agreement and uncertainty metrics provide clinicians with transparent and quantifiable proxies for the reliability and trustworthiness of deep learning segmentation models. This enhanced interpretability can increase clinical acceptance, facilitate critical evaluation of AI-generated segmentations in diagnostic contexts, and ultimately support more confident and informed clinical decision-making, particularly in complex areas like brain tumor analysis.

Limitations

The abstract does not explicitly state limitations. However, implicit considerations could include the generalizability of 'clinician' imaging rankings, the specificity of the BraTS dataset to brain tumors, and the need for broader validation across more diverse medical imaging tasks and pathologies to confirm robustness.

Future Directions

The abstract does not explicitly state future research directions. Potential avenues could involve integrating these interpretable metrics into real-time clinical decision support systems, extending their application to other medical imaging tasks beyond segmentation, and further investigating the definition and acquisition of robust 'clinician' imaging rankings to enhance generalizability.

Medical Domains

Keywords

Abstract

Segmentation is the identification of anatomical regions of interest, such as organs, tissue, and lesions, serving as a fundamental task in computer-aided diagnosis in medical imaging. Although deep learning models have achieved remarkable performance in medical image segmentation, the need for explainability remains critical for ensuring their acceptance and integration in clinical practice, despite the growing research attention in this area. Our approach explored the use of contrast-level Shapley values, a systematic perturbation of model inputs to assess feature importance. While other studies have investigated gradient-based techniques through identifying influential regions in imaging inputs, Shapley values offer a broader, clinically aligned approach, explaining how model performance is fairly attributed to certain imaging contrasts over others. Using the BraTS 2024 dataset, we generated rankings for Shapley values for four MRI contrasts across four model architectures. Two metrics were proposed from the Shapley ranking: agreement between model and ``clinician" imaging ranking, and uncertainty quantified through Shapley ranking variance across cross-validation folds. Higher-performing cases (Dice \textgreater0.6) showed significantly greater agreement with clinical rankings. Increased Shapley ranking variance correlated with decreased performance (U-Net: $r=-0.581$). These metrics provide clinically interpretable proxies for model reliability, helping clinicians better understand state-of-the-art segmentation models.